Prevalence of Substance Use Down in Youth During Pandemic

WEDNESDAY, June 22, 2022 (HealthDay News) -- The prevalence of youth substance use largely declined during the first two years of the pandemic, according to a review recently published in Current Psychiatry Reports.
Hannah M. Layman, from West Virginia University in Morgantown, and colleagues conducted a systematic literature review to assess trends in substance use (across alcohol, cannabis, tobacco, e-cigarettes/vaping, and other drugs and unspecified substances) among youth during the COVID-19 pandemic.
Based on 49 included studies, the researchers found that overall, the prevalence of youth alcohol, cannabis, tobacco, and e-cigarette/vaping use declined during the pandemic. However, for other drugs and unspecified drug and substance use, three studies reported an increase in use and three studies reported a decrease in use.
"One of the driving factors for youth substance use is access to substances," Layman said in a statement. "With stay-at-home orders, virtual schooling and social distancing, children have been spending more time with family and are more socially isolated from peers than before. Although social isolation from peers may have a negative impact on their mental health, it may just be one of the desirable outcomes of the pandemic when considering substance use in children."
Several authors disclosed financial ties to Planet Youth, a youth substance use prevention service organization.
Related Posts
FDA Says Repaired Sleep Apnea Machines Still Carry Health Risks
MONDAY, April 10, 2023 (HealthDay News) -- The U.S. Food and Drug Administration...
AHA News: This Is What a Cardiac Arrest Looks Like, and Why You Need to Know
THURSDAY, Feb. 9, 2023 (American Heart Association News) -- Dr. Anezi Uzendu...
Hay buenos resultados de los primeros 5 años de trasplantes de útero, pero todavía hay preocupaciones
JUEVES, 7 de julio de 2022 (HealthDay News) -- Los trasplantes de útero sí...
Treatment-Resistant Depression Common and Costly
THURSDAY, Dec. 22, 2022 (HealthDay News) -- Treatment-resistant depression (TRD)...